Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Environmental Group Opposes FDA Adding Triclosan To OTC Monographs

This article was originally published in The Tan Sheet

Executive Summary

Environmental regulations could impede a group's attempt to block all non-medical uses of triclosan - including in OTC products

You may also be interested in...



FDA's OTC Antiseptic Rulemaking Has EWG Eyeing Triclosan In Cosmetics

Triclosan eventually may be eliminated entirely from OTC antiseptic drug products through FDA rulemaking, but it's still used in Colgate Total toothpastes to combat gingivitis and in cosmetics where it functions as a preservative. In a newly published paper, the Environmental Working Group and 200 international scientists and medical professionals express concern about the ingredient's use in those categories as well.

Canada To Push For Reduced Triclosan Use In Personal Care Products

A draft safety assessment in Canada says triclosan exposure through the use of personal care products poses little health risk to consumers. But Canadian authorities also find the antimicrobial may pose some environmental risks and may be no more effective in products than available alternatives.

Canada To Push For Reduced Triclosan Use In Personal Care Products

A draft safety assessment in Canada says triclosan exposure through the use of personal care products poses little health risk to consumers. But Canadian authorities also find the antimicrobial may pose some environmental risks and may be no more effective in products than available alternatives.

Related Content

Topics

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel